The Role of Managed Access in a Time of Crisis: A Case Study on How Novartis is Making Critical Impact – Webinar 5/20 at 11am ET
The impact of the Coronavirus (COVID-19) outbreak continues to disrupt our society as we know it, for many becoming a matter of life or death. While there is ongoing research & development work to identify solutions to address the pandemic, managed or expanded access to medicines is now more critical than ever to help address some of the urgent patient needs at various COVID-19 epicenters.
Paul Aliu, Global Head of Medical Governance, Chief Medical Office at Novartis, will share how Novartis was able to quickly mobilize their managed access program to effectively respond to the COVID-19 crisis, managing high volumes of both individual patient, institutional and government requests. Along with Zach Gendron, Senior Account Executive at CyberGrants and expert on managed/expanded access program technology, Paul will examine the key components, methods, strategies and the impact of managed/expanded access during this global pandemic.
Join this live virtual event to hear:
1. How Novartis mobilized managed access programs to respond to the COVID-19 crisis
2. What workflows and processes were needed to respond quickly and efficiently
3. Considerations on data collection and effectiveness measurement
4. Key recommendations for other organizations on how to be able to respond timely in the next crisis
This event will conclude with a live Q&A session.
May 20th, 11am ET